![Image](data:image/png;base64,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)

## SCIENTIFIC REVIEW

## A Systematic Review and Meta-Analysis of Sentinel Lymph Node Biopsy in Gastric Cancer, an Optimization of Imaging Protocol for Tracer Mapping

Yuqiang Huang 1,2 · Mengting Pan 2 · Bo Chen 1,2

Accepted: 27 November 2020 / Published online: 3 January 2021 /C211 Springer Nature Switzerland AG part of Springer Nature 2021

## Abstract

Background Sentinel lymph node biopsy (SLNB) plays an essential role in the evaluation of lymph node (LN) metastasis status and the extent of LN dissection in gastric cancer. The aim of our study was to perform a systematic review and meta-analysis for corresponding identification rate and sensitivity of different SLNB techniques.

Methods Systematic search using PubMed, Embase, and Cochrane library databases was conducted for studies on SLNB in patients with gastric cancer. Studies were stratified according to the sentinel lymph node (SLN) biopsy technique: blue dye (BD), radiocolloid tracer (RI), indocyanine green (ICG), a combination of radiocolloid with blue dye (RI ? BD), and a combination of radiocolloid with ICG (RI ? ICG). A random-effect model was used to pool the identification rate, sensitivity, and accuracy.

Results A total of 54 eligible studies (3767 patients) was included. The pooled identification rates of SLNB using BD, RI, ICG, RI ? BD, RI ? ICG were 95% (95%CI: 92-97%), 95% (95%CI: 93-97%), 99% (95%CI: 97-99%), 97% (95%CI: 96-98%), and 95% (95%CI: 87-99%), respectively. The pooled sensitivities were 82% (95%CI: 77-86%), 87% (95%CI: 81-92%), 90% (95%CI: 82-95%), 89% (95%CI: 84-93%), and 88% (95%CI: 79-94%), respectively. The pooled accuracies were 94% (95%CI: 91-96%), 95% (95%CI: 92-97%), 98% (95%CI: 95-99%), 97% (95%CI: 95-99%), and 98% (95%CI: 95-99%), respectively.

Conclusions The current meta-analysis provides reliable evidence that favors the use of ICG and dual tracer method (RI ? BD/ICG) for the identification of the SLN. Considering the high costs and potential biohazard of using radioactive substances in dual tracer method, performing SLNB with ICG is the technique of choice for experienced surgeons.

## Introduction

Yuqiang Huang and Mengting Pan contributed equally to this work.

Supplementary information The online version contains supplementary material available at (https://doi.org/10.1007/s00268020-05900-9).

& Bo Chen

chenbo7892@xmu.edu.cn

- 1 Department of Clinical Medicine, Fujian Medical University, Fuzhou 350122, China
- 2 Department of Gastrointestinal Surgery, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, 55 Zhenhai Road, Xiamen 361003, China

![Image](data:image/png;base64,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)

Gastric cancer (GC) is one of the most common malignant tumors worldwide and the third leading cause of cancerrelated deaths [1]. Currently, surgical resection with regional lymph node (LN) dissection is main effective intervention for cure or long-term survival of patients with GC, and accurate evaluation of lymph node metastasis is crucial for the choice of treatment options and determining prognosis. Sentinel lymph node (SLN) is defined as the hypothetical first site to receive the lymphatic drainage from the primary tumor. Furthermore, the lymphatic metastatic status of downstream lymph nodes is believed to

![Image](data:image/png;base64,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)

be correlated with the pathological results of SLNs [2]. The concept of SLN has been validated in various tumors, and sentinel lymph node biopsy (SLNB) has been successfully applied with promising results to evaluate the presence of LN metastasis in GC, allowing a reduction in the extent of surgical intervention with limited lymph node dissection [3-5].

In the present study, available methods used for SLN mapping include blue dye (BD), radiocolloid tracer (RI), indocyanine green (ICG), a combination of radiocolloid with blue dye (RI ? BD), and a combination of radiocolloid with ICG (RI ? ICG) [6-8]. However, there is no consensus on the best protocol for its clinical use in SLN mapping and how to supplement or replace other traditional SLNB techniques.

The BD method is convenient and cost-effective. However, it has certain limitations, such as the rapid transit of the dye after injection and loss of visibility in dense adipose tissue, making it hard to detect the true sentinel nodes [9, 10]. Radiocolloid method exhibits poor SLN identification rate because of high background scattering at the primary injection site. Moreover, potential biohazard and legal considerations limit the use of the radioactive probe-guided method in general hospitals [8, 11]. The dual tracer method is considered the most reliable method, but it requires additional endoscopic examination and injection of radiolabeled colloid on the day before surgery. Further, the use of radioactive substances means that the dual tracer method can only be implemented in facilities with radiation-controlled endoscopic laboratories, which leads to high medical expenses and more operative time [12-14].

Recently, ICG infrared or fluorescence imaging has been introduced in the clinical practice as an alternative agent for SLNB guidance. However, the optimal settings of ICG infrared or fluorescence imaging for SLNB, such as ICG concentration and volume, biopsy technique and injection timing, have not been determined. Furthermore, ICG infrared or fluorescence imaging requires special laparoscopic detection equipment [15, 16].

The limitations and characteristics of each mapping technique have an effect on the ability of these modalities to evaluate the status of LN metastasis in gastric cancer, yet accurate evaluation of LN metastasis is crucial for the choice of treatment options and determining prognosis [17]. Therefore, the aim of our study is to provide a detailed meta-analysis on the ability of different SLNB techniques to predict the status of LN metastasis. Additionally, we aim to identify technical aspects influencing the identification rate, sensitivity of SLN mapping.

## Materials and methods

## Search strategy

The preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines were used in conducting this study. A comprehensive electronic literature search was conducted using PubMed, Embase, and Cochrane Library databases from January 1, 2001 to April 25, 2020. Potentially relevant studies were searched using the following search terms ''gastric/stomach'' AND ''cancer/neoplasm/carcinoma/tumor'' AND ''sentinel lymph node/sentinel node''. Through these combined keywords, the primary collection of studies was defined. Furthermore, reference lists of relevant articles and reviews were manually screened for additional eligible studies.

## Inclusion and exclusion criteria

Inclusion criteria were as follows: (1) studies assessed the diagnostic value of BD, RI, ICG, RI ? BD, or RI ? ICG guided SLN mapping in predicting LN status of gastric cancer; (2) histopathological examination was taken as reference standard; (3) studies reported sufficient data of diagnostic performance.

Studies were excluded on the basis of following criteria: (1) studies without original patient data, such as comments, case reports, reviews, editorials, and letters; (2) in vitro studies and animal studies; (3) studies involved patients with several kinds of gastrointestinal malignancies.

Two investigators (YH and MP) independently assessed the eligibility of all retrieved articles using pre-defined inclusion and exclusion criteria. Then, repeated studies were excluded. Finally, each independent selected study was cross-checked by the aforementioned two reviewers. Any disagreement between investigators was resolved with a consensus meeting.

## Data extraction and quality assessment

The following data were extracted by two authors (YH and MP) using pre-designed forms: first author, year of publication, sample size, type of study, tracers, tumor diameter, clinical T stage, injection site, surgical methods, mean number of detected SLNs, methods of SLN biopsy, pathological methods, and test results (identification rate, sensitivity, specificity).

The methodological quality was evaluated by two independent reviewers (YH and MP) using version 2 of the quality assessment of diagnostic accuracy studies (QUADAS-2) tool [18]. QUADAS-2 tool was used to assess the risk of bias and applicability of diagnostic accuracy studies,

and each item was described with: Yes (high quality), No (low quality), or Unclear. Any controversy was resolved by consensus.

## Statistical analysis

The random-effects model based on the DerSimonian and Laird method was applied to pool the SLN identification rate, sensitivity, specificity, accuracy, and negative predictive value (NPV) with 95% confidence interval (CI) [19]. A Z-test was used to compare the pooled estimates of the diagnostic value obtained from different SLNB techniques, and P value \ 0.05 was considered statistically significant. The statistical heterogeneity among studies was evaluated using I 2 statistic, and heterogeneity was considered significant if I 2 value [ 50%.

Additional subgroup analysis to describe heterogeneity and further characterize outcomes was completed for the mean number of detected SLNs, injection site, tumor diameter, pathological methods, methods of SLN biopsy, year of publication, surgical methods, and clinical T stage.

Deeks' funnel plots asymmetry test was used to examine potential publication bias. All statistical analyses were performed using Meta-Disk software Version 1.4 (Javier Zamora, Madrid, Spain) and Stata software Version 16.0 (Stata Corporation, College Station, TX, USA).

## Results

## Study selection and description

The search strategy initially yielded 749 records. After removing duplicates and scanning the titles or abstracts, the remaining 117 studies were further assessed via the fulltext view. After thorough review, 54 studies involving 3,767 patients met the inclusion criteria and were included in this meta-analysis [3, 6, 8, 10, 11, 20-68]. The flow diagram of literature search is shown in Supplementary Fig. 1.

The principal characteristics of each mapping technique (BD, ICG, RI, RI ? BD, and RI ? ICG) are presented in Tables 1,2,3,4,5, respectively. For the evaluation of SLNB using BD (19 studies), a total of 4574 SLNs in 1060 patients was detected, with an average of 4.32 SLNs per patient. For the evaluation of SLNB using RI (9 studies), a total of 1584 SLNs in 477 patients was detected, with an average of 3.32 SLNs per patient. For the evaluation of SLNB using ICG (8 studies), a total of 3002 SLNs in 513 patients was detected, with an average of 5.85 SLNs per patient. ICG fluorescence imaging (4 studies) identified 1036 SLNs in 181 patients with an average of 5.72 SLNs per patient. ICG infrared imaging (4 studies) identified

1966 SLNs in 332 patients with an average of 5.92 SLNs per patient. For the evaluation of SLNB using RI ? BD (12 studies), a total of 5242 SLNs in 1079 patients were detected, with an average of 4.85 SLNs per patient. For the evaluation of SLNB using RI ? ICG (7 studies), a total of 2624 SLNs in 524 patients were detected, with an average of 5.01 SLNs per patient.

## Quality assessment

The QUADAS-2 tool was used to assess the methodological quality of eligible studies, and the results (Supplementary Fig. 2) suggested that all included studies were of moderately high quality. Of these included studies, author's judgement for risk of bias depicted high risk of bias in 7 (13.0%) studies according to patient selection, while 4 (7.4%) studies had high risk of bias according to the index test. Risk of bias regarding reference standard was high in 5 (9.3%) studies. Only 3 (5.6%) studies showed high risk of bias according to the flow and timing. With regards to applicability of the studies, 85.2%, 87.0%, 92.6% of the studies had low concerns in patient selection, index test, and reference standard, respectively. Deeks' funnel plot showed potential publication bias between studies (Supplementary Fig. 3).

## Quantitative analysis

The pooled performance characteristics of all techniques are presented in Supplementary Table 1. The pooled identification rates of SLNB using BD, RI, ICG, RI ? BD, RI ? ICG were 95% (95%CI: 92-97%), 95% (95%CI: 93-97%), 99% (95%CI: 97-100%), 97% (95%CI: 96-98%), and 95% (95%CI: 87-99%), respectively. The pooled sensitivities were 82% (95%CI: 77-86%), 87% (95%CI: 81-92%), 90% (95%CI: 82-95%), 89% (95%CI: 84-93%), and 88% (95%CI: 79-94%), respectively. The pooled accuracies were 94% (95%CI: 91-96%), 95% (95%CI: 92-97%), 98% (95%CI: 95-99%), 97% (95%CI: 95-99%), and 98% (95%CI: 95-99%), respectively. The pooled negative predictive values were 90% (95%CI: 85-94%), 91% (95%CI: 84-96%), 97% (95%CI: 94-99%), 96% (95%CI: 93-98%), and 97% (95%CI: 94-99%), respectively. Overall, ICG and dual tracer method (RI ? BD/ICG) provided improved diagnostic performance compared to the radiocolloid or blue dye.

## Subgroup analysis

The results of subgroup analyses are presented in supplementary Table 2. When solely blue dye was used in SLNB, the mean number of SLNs [ 4 subgroup exhibited a significantly higher sensitivity than SLNs B 4 subgroup (0.87

Table 1 Characteristics of studies evaluating the blue dye technique of sentinel lymph node biopsy in gastric cancer

| Study          |   Year |   Sample size | T stage   | Tumor size(mm)   | Pathology   | Mean SLN   | Injection site   | L/O   | ID (%)   |   SEN (%) |   Accuracy (%) |
|----------------|--------|---------------|-----------|------------------|-------------|------------|------------------|-------|----------|-----------|----------------|
| Bara [20]      |   2019 |            50 | NR        | 48.04            | HE ? IHC    | 7.67       | SS               | O     | 96.0     |      85   |           87.5 |
| Isozaki [21]   |   2019 |           100 | T1        | 22.3             | NR          | 3.8        | SM               | O     | 100.0    |      85.7 |           98   |
| Dong [22]      |   2012 |            23 | T1        | 32               | HE ? IHC    | 2.9        | SM               | L/O   | 100.0    |     100   |          100   |
| Toth [23]      |   2011 |            39 | T1- T3    | NR               | HE ? IHC    | 4.3        | SM/SS            | O     | 97.4     |      95.7 |           97.4 |
| Cozzaglio [24] |   2011 |            29 | T1- T2    | 30               | HE ? IHC    | 2.0        | SM/SS            | O     | 96.6     |      77.3 |           82.1 |
| Rabin [25]     |   2010 |            80 | T1- T3    | NR               | HE ? IHC    | 3.3        | SS               | NR    | 76.3     |      85.4 |           90.2 |
| Becher [26]    |   2009 |            27 | T1- T3    | NR               | HE ? IHC    | 2.7        | SS               | O     | 100.0    |      83.3 |           88.9 |
| Orsenigo [27]  |   2008 |            34 | T1- T2    | 35               | HE ? IHC    | 1.5        | SM               | L     | 79.4     |      41.7 |           74.1 |
| Rino [28]      |   2006 |            38 | T1        | NR               | HE          | 2.5        | SM               | L     | 92.1     |     100   |          100   |
| Rabin [29]     |   2006 |            43 | T1- T3    | NR               | HE ? IHC    | 2.85       | SS               | NR    | 79.1     |      87   |           91.2 |
| Miyake [30]    |   2006 |            76 | T1        | NR               | HE ? IHC    | 6.5        | SM               | L     | 100.0    |      73.3 |           94.7 |
| Ishizaki [31]  |   2006 |           101 | T1- T2    | \ 50             | HE ? IHC    | 6.5        | SM               | O     | 100.0    |      85   |           97   |
| Lee [32]       |   2005 |            71 | T1- T2    | 37               | HE          | 2.5        | SS               | O     | 91.5     |      61.1 |           89.2 |
| Lee [32]       |   2005 |            50 | T1- T2    | 34               | HE          | 2.9        | SM               | O     | 94.0     |      45.5 |           87.2 |
| Gretschel [33] |   2005 |            19 | T1- T2    | \ 50             | HE ? IHC    | NR         | SM               | O     | 100.0    |     100   |          100   |
| Fu [34]        |   2005 |            38 | T1- T3    | NR               | IHC         | NR         | SS               | O     | 100.0    |      83   |           92.1 |
| Song [35]      |   2004 |            27 | T1- T3    | NR               | HE          | 2.7        | SS               | O     | 96.3%    |     100   |          100   |
| Osaka [36]     |   2004 |            57 | T1        | NR               | HE ? IHC    | NR         | SM               | O     | 100.0%   |     100   |          100   |
| Ryu [37]       |   2003 |            71 | T1- T2    | 37               | HE          | 2.5        | SS               | O     | 91.5%    |      61.1 |           89.2 |
| Miwa [38]      |   2003 |           211 | T1        | 25               | HE          | 6.0        | SM               | O     | 96.2%    |      88.6 |           98   |

L laparoscopic surgery; O opening surgery; ID identification rate; SEN sensibility; SM submucosal; SS subserosal; HE hematoxylin-eosin; IHC immunohistochemistry; NR not report; SLN sentinel lymph node

vs. 0.76, P = 0.014). Studies with tumor diameter \ 30 mm showed a higher sensitivity than studies with tumor diameter C 30 mm (0.88 vs. 0.70, P = 0.011).

When solely ICG was used in SLNB, studies with solely cT1 tumors provided increased sensitivity compared to studies with all cT1-3 tumors (0.95 vs. 0.76, P = 0.049).

No significant factors associated with sensitivity were identified for the use of solely radiocolloid, radiocolloid combined with blue dye, and radiocolloid combined with ICG. No significant predictive factors associated with identification rate were identified for any of the techniques (not shown).

## Discussion

Sentinel lymph node biopsy plays an essential role in the evaluation of lymph node metastasis status and the extent of LN dissection in gastric cancer. However, there is no consensus on the best protocol for its clinical use in SLN mapping and how to supplement or replace other traditional SLNB techniques [6-8]. The current study is a detailed systematic review and meta-analysis performed on peer-reviewed scientific articles to evaluate the different SLNB techniques and their clinical applicability.

Table 2 Characteristics of studies evaluating the indocyanine green technique of sentinel lymph node biopsy in gastric cancer

| Study         |   Year |   Sample size | T stage   | Tumor size(mm)   | Pathology   |   Mean SLN | Injection site   | L/O   | Imaging system   |   ID (%) |   SEN (%) |   Accuracy (%) |
|---------------|--------|---------------|-----------|------------------|-------------|------------|------------------|-------|------------------|----------|-----------|----------------|
| Shida [39]    |   2018 |            60 | T1        | 23               | HE          |        5   | SM               | L     | IREE             |    100   |     100   |          100   |
| Takahashi [8] |   2017 |            44 | T1        | 24.8             | HE          |        7.9 | SM               | L     | IRLS             |    100   |     100   |          100   |
| Tummers [40]  |   2016 |            22 | T1- T4    | 35               | HE          |        3.1 | SS               | O     | FI               |     95.5 |      75   |           90.5 |
| Kinami [41]   |   2016 |            72 | T1        | 27.5             | HE          |        5   | SM               | L/O   | FI               |    100   |      90.9 |           98.6 |
| Miyashiro [3] |   2011 |            10 | T1        | NR               | HE          |        3   | NR               | L     | FI               |    100   |     100   |          100   |
| Tajima [42]   |   2010 |            77 | T1- T2    | 34.9             | HE          |        7.5 | SM/SS            | L/O   | FI               |     94.8 |      76.5 |           94.5 |
| Kelder [43]   |   2010 |           212 | T1        | 30               | HE          |        6   | SM               | L/O   | IREE             |     99.5 |      97   |           99.5 |
| Ishikawa [44] |   2007 |            16 | T1        | 21               | HE          |        2.9 | SM               | L     | IREE             |    100   |      50   |           93.8 |

L laparoscopic surgery, O opening surgery, SM submucosal, SS subserosal, HE hematoxylin-eosin, IHC immunohistochemistry, NR not report, SLN sentinel lymph node, ID identification rate, SEN sensibility, IREE infrared ray electronic endoscopy system, IRLS infrared ray laparoscopic system, FI fluorescence imaging system

Table 3 Characteristics of studies evaluating the radioisotope technique of sentinel lymph node biopsy in gastric cancer

| Study             |   Year |   Sample size | T stage   | Tumor size(mm)   | Pathology   |   Mean SLN | Injection site   | L/ O   |   ID (%) |   SEN (%) |   Accuracy (%) |
|-------------------|--------|---------------|-----------|------------------|-------------|------------|------------------|--------|----------|-----------|----------------|
| Jalaly [10]       |   2014 |            30 | T1-T3     | NR               | HE ? IHC    |        2.2 | SM               | O      |    100   |      91.7 |           93.3 |
| Su [45]           |   2010 |            31 | T1-T3     | NR               | HE ? IHC    |        2.8 | SM               | O      |    100   |      86.4 |           90.3 |
| Mochiki [46]      |   2006 |            59 | T1-T3     | NR               | HE          |        3.8 | SM               | NR     |     96.6 |      83.3 |           93   |
| Zulfikaroglu [47] |   2005 |            32 | T1-T3     | NR               | HE ? IHC    |        2.4 | SM               | NR     |     96.9 |     100   |           96.8 |
| Uenosono [48]     |   2005 |           104 | T1-T2     | 34.3             | HE ? IHC    |        4.1 | SM               | O      |     95.2 |      78.6 |           93.9 |
| Gretschel [33]    |   2005 |            15 | T1-T2     | \ 50             | HE ? IHC    |        3   | SM               | O      |     93.3 |      88.9 |           92.9 |
| Kim [49]          |   2004 |            46 | T1-T2     | 23               | HE ? IHC    |        2   | SM               | NR     |     93.5 |      84.6 |           95.3 |
| Gretschel [50]    |   2003 |            15 | T1-T3     | NR               | HE ? IHC    |        3   | SM               | O      |     93.3 |      88.9 |           92.9 |
| Kitagawa [11]     |   2002 |           145 | T1-T2     | NR               | HE          |        3.6 | SM               | NR     |     95.2 |      91.7 |           98.6 |

L laparoscopic surgery; O opening surgery; ID identification rate; SEN sensibility; SM submucosal; SS subserosal; HE hematoxylin-eosin; IHC immunohistochemistry; NR not report; SLN sentinel lymph node

## Evaluation of lymph node status by SLNB

The results of this meta-analysis indicated that compared with the use of BD or RI method, SLNB using ICG or RI ? BD exhibited higher identification rates (99% and 98%, respectively). Furthermore, the pooled identification rate, sensitivity and NPV for all SLNB techniques steadily increased over time. For SLNB using ICG, the pooled identification rate, sensitivity and NPV of SLNB in patients with gastric cancer have increased from 98%, 88%, and 96% in 2001-2010 to 99%, 92%, and 98% in 2011-2020.

Thus, we believe that the experience of surgeons and application frequency would improve with time, which may be an important factor in the steady increase in diagnostic efficacy of SLNB.

Theoretically, the diagnostic performance of SLNB using RI ? ICG should be significantly improved compared to using solely ICG. Nevertheless, the current study showed no significant difference between patients using solely ICG and RI ? ICG in SLNB with regards to identification rate (99% vs. 95%, P = 0.205) and sensitivity (90% vs. 88%, P = 0.693). Also, there was no significant

Table 4 Characteristics of studies evaluating both radioisotope and blue dye technique of sentinel lymph node biopsy in gastric cancer

| Study          |   Year |   Sample size | T stage   | Tumor size(mm)   | Pathology   |   Mean SLN | Injection site   | L/O   |   ID (%) |   SEN (%) |   Accuracy (%) |
|----------------|--------|---------------|-----------|------------------|-------------|------------|------------------|-------|----------|-----------|----------------|
| Mueller [51]   |   2019 |            10 | T1-T2     | \ 30             | NR          |       5    | SM               | L     |     90   |     100   |          100   |
| Ohi [52]       |   2019 |            26 | T1        | 24               | HE          |       3.54 | NR               | L     |    100   |      66.7 |           96.2 |
| Niihara [53]   |   2016 |           385 | T1-T2     | \ 40             | HE          |       4.7  | SM               | L/O   |     96.6 |      89.5 |           98.9 |
| Kitagawa [54]  |   2013 |           397 | T1-T2     | 30               | HE          |       5.6  | SM               | L     |     97.5 |      93   |           99   |
| Gretschel [55] |   2007 |            35 | T1-T2     | 32               | HE ? IHC    |       3    | SM               | O     |     97.1 |      91.7 |           94.1 |
| Mura [56]      |   2006 |            10 | T1        | NR               | HE ? IHC    |       3.1  | SM               | NR    |    100   |      50   |           90   |
| Lee [57]       |   2006 |            64 | T1        | 35               | HE ? IHC    |       4.1  | SM               | O     |     96.9 |      70.6 |           91.9 |
| Tonouchi [58]  |   2005 |            37 | T1-T2     | NR               | HE ? IHC    |       4    | SM               | L/O   |     94.6 |      75   |           97.1 |
| Cheng [59]     |   2005 |            26 | T1-T3     | NR               | NR          |       3.2  | SM               | O     |     96.2 |      94.4 |           96   |
| Karube [60]    |   2004 |            41 | T1-T2     | NR               | HE ? IHC    |       5    | SM               | NR    |    100   |      92.3 |           97.6 |
| Tonouchi [61]  |   2003 |            17 | T1        | NR               | HE ? IHC    |       4.2  | SM               | L     |    100   |     100   |          100   |
| Hayashi [62]   |   2003 |            31 | T1-T2     | NR               | HE          |       5.2  | SM               | O     |    100   |     100   |          100   |

L laparoscopic surgery; O opening surgery; ID identification rate; SEN sensibility; SM submucosal; SS subserosal; HE hematoxylin-eosin; IHC immunohistochemistry; NR not report; SLN sentinel lymph node

Table 5 Characteristics of studies evaluating both radioisotope and indocyanine green technique of sentinel lymph node biopsy in gastric cancer

| Study           |   Year |   Sample size | T stage   | Tumor size(mm)   | Pathology   |   Mean SLN | Injection site   | L/ O   | Imaging system   |   ID (%) |   SEN (%) |   Accuracy (%) |
|-----------------|--------|---------------|-----------|------------------|-------------|------------|------------------|--------|------------------|----------|-----------|----------------|
| Park [63]       |   2018 |           100 | T1        | 20               | HE ? IHC    |        6.1 | SM               | L      | Naked eyes       |    100   |      84.6 |           98   |
| Kamiya [64]     |   2016 |            72 | T1        | 25.2             | HE          |        4   | SM               |        | NR Naked eyes    |    100   |      63.6 |           94.4 |
| Lee [65]        |   2015 |           108 | T1-       | 25               | HE          |        7   | SM               | L      | Naked eyes       |     92.6 |     100   |          100   |
| Park [6]        |   2011 |            68 | T1-       | \ 40             | HE ? IHC    |        3.3 | SM               | L      | Naked eyes       |     91.2 |     100   |          100   |
| Yaguchi [66]    |   2008 |            43 | T1- T2    | 28               | NR          |        5   | SM               | O      | Naked eyes       |    100   |      85.7 |           97.7 |
| Yaguchi [66]    |   2008 |            20 | T1- T2    | 28               | NR          |        6   | SS               | O      | Naked eyes       |    100   |     100   |          100   |
| Lee, Y. J. [67] |   2008 |            42 | T1- T2    | 33               | HE          |        2.1 | SM               | L      | Naked eyes       |     54.8 |      66.7 |           91.3 |
| Lee, Y. J. [67] |   2008 |            50 | T1- T2    | 31               | HE          |        3.5 | SM               | L      | Naked eyes       |     96   |      85.7 |           95.8 |
| Lee, J. H. [68] |   2008 |            21 | T1        | 31               | HE ? IHC    |        7   | SM               | L      | Naked eyes       |     95.2 |     100   |          100   |

L laparoscopic surgery; O opening surgery; ID identification rate; SEN sensibility; SM submucosal; SS subserosal; HE hematoxylin-eosin; IHC immunohistochemistry; NR not report; SLN sentinel lymph node

difference between patients using solely ICG and RI ? BD in SLNB with regards to sensitivity (90% vs. 89%, P = 0.804). Additionally, SLNB using solely ICG exhibited a higher pooled identification rate than RI ? BD (99% vs. 97%, P = 0.029). These results of the current study

suggested that compared with solely ICG, the dual tracer method (RI ? BD/ICG) did not further increase the identification rate and sensitivity of SLNB.

Furthermore, there are some disadvantages of the use of radioactive substances in dual tracer method. First, the use

of radioactive substances is associated with high costs and potential biohazard, and demands specific logistical arrangements according to regulations regarding handling radioactive substances, therefore restricting its clinical application in some hospitals. Another major limitation of radiocolloid is the shine-through effect from the injection site that can interfere with the ''hot node'' detection [8, 55]. In addition, global shortage of technetium-99 m had been encountered on multiple occasions, and the extremely poor sustainability highlights the need to find alternatives.

Although the blue dye is convenient and cost-effective, the reduced visibility of the blue dye in dense adipose tissue and poor tissue contrast make it extremely difficult to detect SLNs in deep, dark anatomical regions, such as the abdomen [69]. A further potential limitation is the possibility of inducing allergic reactions. These limitations are more critical in laparoscopic surgery. Thus, improvement of the detection method is vital for clinical application of the laparoscopic SLNB.

To overcome these limitations, ICG, as an alternative to the conventional SLN detection methods of BD and RI, has been introduced for SLN mapping during gastric cancer surgery, and has produced favorable outcomes [70].

ICG is a popular diagnostic reagent that is approved for clinical use in the laboratory. ICG possesses a maximum absorption wavelength of 800 nm in the near-infrared range, and emits a maximum fluorescence wavelength of 840 nm when it binds to plasma proteins [41, 69]. Utilizing this principle of ICG, the infrared ray endoscopy system uses infrared rays at a wavelength of around 805 nm, and the fluorescent imaging system is fitted with a light emitting diode (LED) emitting light at the wavelength of 760 nm and a charge-coupled device camera with a cut filter used to filter out light with a wavelength below 820 nm, so as to enhance the visualization of dye within human tissue [15, 16]. Other studies reported that ICG fluorescence imaging allowed more clear and bright visualization than infrared imaging [71]. However, the current study exhibited no significant difference between patients using ICG infrared imaging and fluorescence imaging in SLNB with regards to identification rate (99% vs. 97%, P = 0.342) and sensitivity (96% vs. 82%, P = 0.059).

Many advantages and its clinical applicability of ICG have been emphasized compared with other conventional SLN detection methods. However, the best procedure and suitable criteria of ICG infrared or fluorescence imaging for SLNB, such as ICG concentration, ICG volume, injection site, the observation timing after injection and patient selection, have not been determined [41]. Furthermore, the multi-center prospective study JCOG0302 using ICG was terminated early due to an unacceptable false negative rate, and further analysis conducted by Miyashiro et al. [72] revealed the unreliability of intraoperative

single-plane frozen section and highlighted the impact of the learning curve. Therefore, this method should be performed in the hands of an experienced surgeon.

In the present study, the average number of SLNs per patient obtained by SLNB using ICG or ICG ? RI was considerably higher (ICG: 5.85 SLNs, ICG ? RI: 5.01 SLNs) compared with the use of BD (4.32 SLNs), RI (3.32 SLNs), BD ? RI (4.85 SLNs). This difference might be explained by the low molecular weight of ICG and hence rapid migration through the SLN to second tier nodes, resulting in resection and pathological assessment of multiple nodes.

## Factors influencing the diagnostic performance of SLNB

Of all variables evaluated, selection of patients with solely T1 gastric cancer (vs. T1-T3 gastric cancer; 0.95 vs. 0.76, P = 0.049) was associated with an improved sensitivity for SLNB using ICG. For the use of BD in SLNB, selection of patients with tumor diameter less than 30 mm was associated with an improved SLN sensitivity (vs. C 30 mm; 0.88 vs. 0.69, P = 0.005). No significant factors associated with sensitivity were identified for the use of solely radiocolloid, radiocolloid combined with blue dye, and radiocolloid combined with ICG.

This meta-analysis contains several limitations. First, despite our attempts to include all relevant studies, Deeks' funnel plot asymmetry test still showed potential publication bias, which may limit the stability of the pooled result. Second, the end points were restricted to be SLN identification rate and sensitivity of different SLNB techniques rather than more important outcome measures such as overall survival and locoregional recurrence rate.

## Conclusion

The current meta-analysis provides reliable evidence that favors the use of ICG and dual tracer method (RI ? BD/ ICG) for the identification of the SLN. Considering the high costs and potential biohazard of using radioactive substances in dual tracer method, performing SLNB with ICG is the technique of choice for experienced surgeons.

Funding This research was supported by the Natural Science Foundation of Fujian Province (Grant No. 2018J01377).

## Compliance with ethical standards

Conflict of interest The authors declare that they have no conflict of interest.

## References

- 1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394-424
- 2. Straver ME, Meijnen P, van Tienhoven G et al (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 17:1854-1861
- 3. Miyashiro I, Kishi K, Yano M et al (2011) Laparoscopic detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging. Surg Endosc 25:1672-1676
- 4. Yoshida M, Kubota K, Kuroda J et al (2012) Indocyanine green injection for detecting sentinel nodes using color fluorescence camera in the laparoscopy-assisted gastrectomy. J Gastroenterol Hepatol 27(Suppl 3):29-33
- 5. Takeuchi H, Kitagawa Y (2013) New sentinel node mapping technologies for early gastric cancer. Ann Surg Oncol 20:522-532
- 6. Park DJ, Kim HH, Park YS et al (2011) Simultaneous indocyanine green and (99 m)Tc-antimony sulfur colloid-guided laparoscopic sentinel basin dissection for gastric cancer. Ann Surg Oncol 18:160-165
- 7. Saikawa Y, Otani Y, Kitagawa Y et al (2006) Interim results of sentinel node biopsy during laparoscopic gastrectomy: possible role in function-preserving surgery for early cancer. World J Surg 30:1962-1968. https://doi.org/10.1007/s00268-006-0142-1
- 8. Takahashi N, Nimura H, Fujita T et al (2017) Laparoscopic sentinel node navigation surgery for early gastric cancer: a prospective multicenter trial. Langenbecks Arch Surg 402:27-32
- 9. Skubleny D, Dang JT, Skulsky S et al (2018) Diagnostic evaluation of sentinel lymph node biopsy using indocyanine green and infrared or fluorescent imaging in gastric cancer: a systematic review and meta-analysis. Surg Endosc 32:2620-2631
- 10. Jalaly NY, Valizadeh N, Azizi S et al (2014) Sentinel lymph node mapping and biopsy using radioactive tracer in gastric cancer. ANZ J Surg 84:454-458
- 11. Kitagawa Y, Fujii H, Mukai M et al (2002) Radio-guided sentinel node detection for gastric cancer. Br J Surg 89:604-608
- 12. Shoji Y, Kumagai K, Kamiya S et al (2019) Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery. Gastric Cancer 22:873-880
- 13. Bostick P, Essner R, Glass E et al (1999) Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg 134:43-49
- 14. Giuliano AE, Jones RC, Brennan M et al (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350
- 15. Takahashi N, Nimura H, Fujita T et al (2016) Quantitative assessment of visual estimation of the infrared indocyanine green imaging of lymph nodes retrieved at sentinel node navigation surgery for gastric cancer. BMC Surg 16:35
- 16. Tajima Y, Yamazaki K, Masuda Y et al (2009) Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer. Ann Surg 249:58-62
- 17. Morgan JW, Ji L, Friedman G et al (2015) The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery. JAMA Surg 150:37-43
- 18. Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529-536
- 19. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
- 20. Bara T Jr, Gurzu S, Jung I et al (2019) Sentinel node biospy using intravital blue dye: an useful technique for identification of skip metastases in gastric cancer. Medicine (Baltimore) 98:e14951
- 21. Isozaki H, Matsumoto S, Murakami S (2019) Survival outcomes after sentinel node navigation surgery for early gastric cancer. Ann Gastroenterol Surg 3:552-560
- 22. Dong LF, Wang LB, Shen JG et al (2012) Sentinel lymph node biopsy predicts lymph node metastasis in early gastric cancer: a retrospective analysis. Dig Surg 29:124-129
- 23. Toth D, Kincses Z, Plosz J et al (2011) Value of sentinel lymph node mapping using a blue dye-only method in gastric cancer: a single-center experience from North-East Hungary. Gastric Cancer 14:360-364
- 24. Cozzaglio L, Bottura R, Di Rocco M et al (2011) Sentinel lymph node biopsy in gastric cancer: possible applications and limits. Eur J Surg Oncol 37:55-59
- 25. Rabin I, Chikman B, Lavy R et al (2010) The accuracy of sentinel node mapping according to T stage in patients with gastric cancer. Gastric Cancer 13:30-35
- 26. Becher RD, Shen P, Stewart JH et al (2009) Sentinel lymph node mapping for gastric adenocarcinoma. Am Surg 75:710-714
- 27. Orsenigo E, Tomajer V, Di Palo S et al (2008) Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer. Surg Endosc 22:118-121
- 28. Rino Y, Takanashi Y, Harada H et al (2006) Technique and assessment of sentinel lymph node biopsy usefulness in laparoscopy-assisted distal gastrectomy. Surg Endosc 20:1887-1891
- 29. Rabin I, Chikman B, Halpern Z et al (2006) Sentinel node mapping for gastric cancer. Isr Med Assoc J 8:40-43
- 30. Miyake K, Seshimo A, Kameoka S (2006) Assessment of lymph node micrometastasis in early gastric cancer in relation to sentinel nodes. Gastric Cancer 9:197-202
- 31. Ishizaki M, Kurita A, Kubo Y et al (2006) Evaluation of sentinel node identification with isosulfan blue in gastric cancer. Eur J Surg Oncol 32:191-196
- 32. Lee JH, Ryu KW, Kim CG et al (2005) Comparative study of the subserosal versus submucosal dye injection method for sentinel node biopsy in gastric cancer. Eur J Surg Oncol 31:965-968
- 33. Gretschel S, Bembenek A, Ulmer C et al (2005) Prediction of gastric cancer lymph node status by sentinel lymph node biopsy and the Maruyama computer model. Eur J Surg Oncol 31:393-400
- 34. Fu XB, Hu X (2005) Localization and pathological examination of sentinel lymph node during operation in gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 8:29-31
- 35. Song X, Wang L, Chen W et al (2004) Lymphatic mapping and sentinel node biopsy in gastric cancer. Am J Surg 187:270-273
- 36. Osaka H, Yashiro M, Sawada T et al (2004) Is a lymph node detected by the dye-guided method a true sentinel node in gastric cancer? Clin Cancer Res 10:6912-6918
- 37. Ryu KW, Lee JH, Kim HS et al (2003) Prediction of lymph nodes metastasis by sentinel node biopsy in gastric cancer. Eur J Surg Oncol 29:895-899
- 38. Miwa K, Kinami S, Taniguchi K et al (2003) Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg 90:178-182
- 39. Shida A, Mitsumori N, Fujioka S et al (2018) Sentinel node navigation surgery for early gastric cancer: analysis of factors which affect direction of lymphatic drainage. World J Surg 42:766-772. https://doi.org/10.1007/s00268-017-4226-x
- 40. Tummers QR, Boogerd LS, de Steur WO et al (2016) Nearinfrared fluorescence sentinel lymph node detection in gastric cancer: a pilot study. World J Gastroenterol 22:3644-3651
- 41. Kinami S, Oonishi T, Fujita J et al (2016) Optimal settings and accuracy of indocyanine green fluorescence imaging for sentinel node biopsy in early gastric cancer. Oncol Lett 11:4055-4062

- 42. Tajima Y, Murakami M, Yamazaki K et al (2010) Sentinel node mapping guided by indocyanine green fluorescence imaging during laparoscopic surgery in gastric cancer. Ann Surg Oncol 17:1787-1793
- 43. Kelder W, Nimura H, Takahashi N et al (2010) Sentinel node mapping with indocyanine green (ICG) and infrared ray detection in early gastric cancer: an accurate method that enables a limited lymphadenectomy. Eur J Surg Oncol 36:552-558
- 44. Ishikawa K, Yasuda K, Shiromizu A et al (2007) Laparoscopic sentinel node navigation achieved by infrared ray electronic endoscopy system in patients with gastric cancer. Surg Endosc 21:1131-1134
- 45. Su XH, Chen Q, Sun L et al (2010) Location of sentinel lymph node in gastric cancer: A modified, painless and noninvasive approach. Chin J Cancer Res 22:55-61
- 46. Mochiki E, Kuwano H, Kamiyama Y et al (2006) Sentinel lymph node mapping with technetium-99m colloidal rhenium sulfide in patients with gastric carcinoma. Am J Surg 191:465-469
- 47. Zulfikaroglu B, Koc M, Ozmen MM et al (2005) Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery 138:899-904
- 48. Uenosono Y, Natsugoe S, Ehi K et al (2005) Detection of sentinel nodes and micrometastases using radioisotope navigation and immunohistochemistry in patients with gastric cancer. Br J Surg 92:886-889
- 49. Kim MC, Kim HH, Jung GJ et al (2004) Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer. Ann Surg 239:383-387
- 50. Gretschel S, Bembenek A, Ulmer C et al (2003) Lymphatic mapping and sentinel lymph node biopsy in gastric cancer. Chirurg 74:132-138
- 51. Mueller CL, Lisbona R, Sorial R et al (2019) Sentinel lymph node sampling for early gastric cancer-preliminary results of a north american prospective study. J Gastrointest Surg 23:1113-1121
- 52. Ohi M, Toiyama Y, Omura Y et al (2019) Possibility of limited gastrectomy for early gastric cancer located in the upper third of the stomach, based on the distribution of sentinel node basins. Surg Today 49:529-535
- 53. Niihara M, Takeuchi H, Nakahara T et al (2016) Sentinel lymph node mapping for 385 gastric cancer patients. J Surg Res 200:73-81
- 54. Kitagawa Y, Takeuchi H, Takagi Y et al (2013) Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol 31:3704-3710
- 55. Gretschel S, Bembenek A, Hunerbein M et al (2007) Efficacy of different technical procedures for sentinel lymph node biopsy in gastric cancer staging. Ann Surg Oncol 14:2028-2035
- 56. Mura G, Vagliasindi A, Framarini M et al (2006) The sentinel node biopsy in early gastric cancer: a preliminary study. Langenbecks Arch Surg 391:113-117
- 57. Lee JH, Ryu KW, Kim CG et al (2006) Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Ann Surg Oncol 13:1168-1174
- 58. Tonouchi H, Mohri Y, Tanaka K et al (2005) Laparoscopic lymphatic mapping and sentinel node biopsies for early-stage gastric cancer: the cause of false negativity. World J Surg 29:418-421

- 59. Cheng LY, Chen XD, Zhang YX et al (2005) Clinical significance of sentinel lymph node detection by combining the dyedirected and radioguided methods in gastric cancer. Zhonghua Wai Ke Za Zhi 43:569-572
- 60. Karube T, Ochiai T, Shimada H et al (2004) Detection of sentinel lymph nodes in gastric cancers based on immunohistochemical analysis of micrometastases. J Surg Oncol 87:32-38
- 61. Tonouchi H, Mohri Y, Tanaka K et al (2003) Lymphatic mapping and sentinel node biopsy during laparoscopic gastrectomy for early cancer. Dig Surg 20:421-427
- 62. Hayashi H, Ochiai T, Mori M et al (2003) Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. J Am Coll Surg 196:68-74
- 63. Park DJ, Park YS, Son SY et al (2018) Long-term oncologic outcomes of laparoscopic sentinel node navigation surgery in early gastric cancer: a single-center, single-arm, phase II trial. Ann Surg Oncol 25:2357-2365
- 64. Kamiya S, Takeuchi H, Nakahara T et al (2016) Auxiliary diagnosis of lymph node metastasis in early gastric cancer using quantitative evaluation of sentinel node radioactivity. Gastric Cancer 19:1080-1087
- 65. Lee YJ, Jeong SH, Hur H et al (2015) Prospective multicenter feasibility study of laparoscopic sentinel basin dissection for organ preserving surgery in gastric cancer: quality control study for surgical standardization prior to phase III trial. Medicine (Baltimore) 94:e1894
- 66. Yaguchi Y, Ichikura T, Ono S et al (2008) How should tracers be injected to detect for sentinel nodes in gastric cancer-submucosally from inside or subserosally from outside of the stomach? J Exp Clin Cancer Res 27:79
- 67. Lee YJ, Ha WS, Park ST et al (2008) Which biopsy method is more suitable between a basin dissection and pick-up biopsy for sentinel nodes in laparoscopic sentinel-node navigation surgery (LSNNS) for gastric cancer? J Laparoendosc Adv Surg Tech A 18:357-363
- 68. Lee JH, Ryu KW, Kook MC et al (2008) Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer. J Surg Oncol 98:331-335
- 69. Kusano M, Tajima Y, Yamazaki K et al (2008) Sentinel node mapping guided by indocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastrointestinal cancer. Dig Surg 25:103-108
- 70. Kitai T, Inomoto T, Miwa M et al (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211-215
- 71. Miyashiro I, Miyoshi N, Hiratsuka M et al (2008) Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: comparison with infrared imaging. Ann Surg Oncol 15:1640-1643
- 72. Miyashiro I, Hiratsuka M, Sasako M et al (2014) High falsenegative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan clinical oncology group multicenter trial JCOG0302. Gastric Cancer 17:316-323

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.